×
About 1,095 results

ALLMedicine™ Hypernatremia Center

Research & Reviews  385 results

Association Between Serum Sodium and Long-Term Mortality in Critically Ill Patients wit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112792
International Journal of Chronic Obstructive Pulmonary Di... Fan L, Sun D et. al.

May 20th, 2022 - The purpose of our study was to investigate the relationship between serum sodium levels and 1-year and 3-year mortality in critically ill patients with comorbid chronic obstructive pulmonary disease using real-world data. The data of this study w...

Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients.
https://doi.org/10.1530/EJE-22-0023
European Journal of Endocrinology; Refardt J, Brabander T et. al.

May 14th, 2022 - Hyponatremia and hypernatremia are common electrolyte abnormalities in patients with malignancy and have been independently associated with worse survival outcomes. To date, there are no data on the impact of dysnatremia on survival outcome in pat...

Specific Gravity
https://emedicine.medscape.com/article/2090711-print

May 12th, 2022 - Urinary specific gravity (SG) is a measure of the concentration of solutes in the urine. It measures the ratio of urine density compared with water density and provides information on the kidney’s ability to concentrate urine. A urinary specific g...

Identification of Clinical Factors Related to Antibody-Mediated Immune Response to the ...
https://doi.org/10.1111/cen.14737
Clinical Endocrinology; Nakamura-Utsunomiya A, Goda S et. al.

Apr 15th, 2022 - We recently reported cases of adipsic hypernatremia caused by autoantibodies against the subfornical organ in patients with hypothalamic-pituitary lesions. This study aimed to clarify the clinical features of newly identified patients with adipsic...

Licorice Poisoning
https://emedicine.medscape.com/article/817578-overview

Apr 11th, 2022 - Practice Essentials Natural licorice is an extract from the root of Glycyrrhiza glabra, a 4- to 5-foot woody shrub that contains glycyrrhizic acid (GZA) and grows in subtropical climates in Europe, the Middle East, and Western Asia. Licorice extra...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  16 results

To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
https://clinicaltrials.gov/ct2/show/NCT05060523

Nov 29th, 2021 - Aim and Objective - AIM: • To study effect of the combination of Midodrine and Tolvaptan versus Tolvaptan alone in patients with severe hyponatremia in cirrhosis. PRIMARY Objective : • To study the Improvement in sodium concentration from base lin...

Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients
https://clinicaltrials.gov/ct2/show/NCT02914782

Jun 18th, 2021 - Critically ill patients need intravenous fluid therapy in order to correct or prevent problems with their fluid and/or electrolyte status and for renal protection. The decision for the optimal composition and amount of IV-fluids can be difficult a...

Comparison of the Isotonic and Hypotonic Intravenous Maintenance Fluids In Term Newborns: Neofluid Study
https://clinicaltrials.gov/ct2/show/NCT04781361

Mar 12th, 2021 - Considering the physiological changes in fluid and electrolyte balance and providing proper support are one of the important aspects of neonatal intensive care. Maintenance intravenous fluids are designed to maintain homeostasis when a patient is ...

Sodium Status in Septic Patients and Its Relation to Prognosis an Hospital Stay
https://clinicaltrials.gov/ct2/show/NCT04564508

Jan 12th, 2021 - Sepsis and septic shock are among the most prevalent causes of intensive care unit (ICU) admissions. They account for around 10-50% of the mortality rate, which remains high despite extensive research of the Surviving Sepsis Campaign, and national...

Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus
https://clinicaltrials.gov/ct2/show/NCT02967653

Sep 16th, 2020 - Lithium remains the gold-standard treatment for bipolar disorder, with 30-40% of patients with responding preferentially to this medication. Additionally, lithium is commonly used in treatment-resistant depression, and other psychiatric disorders ...

see more →

News  30 results

Top strategies for preventing tardive dyskinesia
https://www.mdedge.com/psychiatry/article/251979/movement-disorders/top-strategies-preventing-tardive-dyskinesia
Doug Brunk

Feb 18th, 2022 - LAS VEGAS – In the opinion of Christoph U. Correll, MD, tardive dyskinesia (TD) “has been somewhat forgotten” by psychiatrists because the risk of patients developing the condition is considered to be significantly lower with second-generation ant.

Bempegaldesleukin/Nivolumab Combo Upholds Durable Benefit in Metastatic Melanoma
https://www.onclive.com/view/bempegaldesleukin-nivolumab-combo-upholds-durable-benefit-in-metastatic-melanoma

Oct 6th, 2021 - November 13, 2020 - The combination of bempegaldesleukin (NKTR-214) and the PD-1 inhibitor nivolumab (Opdivo) elicited a confirmed best overall response rate (ORR) of 53% in efficacy-evaluable patients with metastatic melanoma, according to update...

Inpatient Sodium Imbalances Linked to Adverse COVID-19 Outcomes
https://www.medscape.com/viewarticle/947165

Mar 10th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Both high and low serum sodium levels are associated with adverse outcomes for hospitalized patients with COVID-19, new research suggests. In the ...

Isotonic Fluids Without Potassium Could Be Harmful for Some Acutely Ill Kids
https://www.medscape.com/viewarticle/939875

Oct 28th, 2020 - NEW YORK (Reuters Health) - A recent move to use isotonic rather than hypotonic intravenous fluids (IVFs) in acutely ill children could be boosting their risk of developing electrolyte disorders, a new trial suggests. "Commercially available isoto...

AUTO3 CAR T-Cell Product Plus Pembrolizumab Shows Clinical Activity, Tolerability in Relapsed/Refractory DLBCL
https://www.onclive.com/view/auto3-car-t-cell-product-plus-pembrolizumab-shows-clinical-activity-tolerability-in-relapsed-refractory-dlbcl

Sep 23rd, 2020 - The investigational CAR T-cell product AUTO3 in combination with pembrolizumab (Keytruda) was found to have a tolerable safety profile and elicit durable complete responses (CRs) in patients with relapsed/refractory diffuse large B-cell lymphoma (...

see more →